Stereoselective binding of etodolac to human serum albumin.
The protein binding of etodolac enantiomers was studied in vitro by equilibrium dialysis in human serum albumin (HSA) of various concentrations varying from 1 to 40 g/liter, by addition of each enantiomer at increasing concentrations. In the 1 g/liter solution, at the lowest drug levels, the (R)-form is more bound than its antipode, the contrary being observed at the highest drug levels. For higher albumin concentrations, S was bound in a larger extent than R. Using the displacement of specific markers of HSA sites I and II, studied by spectrofluorimetry, it was suggested that R and S are both bound to site I, while only S is strongly bound to site II.
Muller
N
N
Laboratoire de Pharmacologie, URA CNRS 1288, Faculté de Médecine, Vandoeuvre les Nancy, France.
Lapicque
F
F
Monot
C
C
Payan
E
E
Dropsy
R
R
Netter
P
P
D000894:Anti-Inflammatory Agents, Non-Steroidal / Q000378:metabolism*; D001665:Binding Sites; D003956:Dialysis; D017308:Etodolac / Q000378:metabolism*; D006801:Humans; D011485:Protein Binding; D012709:Serum Albumin / Q000378:metabolism*; D013050:Spectrometry, Fluorescence; D013237:Stereoisomerism
D000894:Anti-Inflammatory Agents, Non-Steroidal; D012709:Serum Albumin; D017308:Etodolac